Patent · US Active

Anti-VEGF-A and anti-ANG2 antibodies and uses thereof

US10836819B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

MedImmune Limited · US

Inventors

Ching Ching Leow · Gaithersburg, US
Nazzareno Dimasi · Gaithersburg, US
Karen Coffman · Pawcatuck, US
Ryan Fleming · Gaithersburg, US
Ping Tsui · Gaithersburg, US
Changshou Gao · Potomac, US
Mario A. Cepeda · Winchester, US
Adrian Schwartz Mittelman · Brookfield, US

Key dates

Filing date	Aug 22, 2017
Grant date	Nov 17, 2020
Priority date	—
Expiry date	Aug 22, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2015/8518
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to bispecific antibodies having activity against a vascular endothelial growth factor (VEGF) and an angiopoietin (ANG), and methods of making and using such bispecific antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.